Recent Seminars


Gordon Lecture: Methodology Development with Carbon-11 and Fluorine-18 for PET Applications

08/19/2019


So Jeong Lee is currently a postdoctoral fellow at PET center in the Department of Radiology at the University of Michigan working with Prof. Peter J. H. Scott. She obtained her B.S and B.E in Chemistry and Material Science at SUNY Stony Brook University in 2010 and her Ph.D in Chemistry from Stony Brook University and BNL under Prof. Joanna S. Fowler’s mentorship in 2015.
Below is a summary of her presentation.

Positron emission tomography (PET) is a functional imaging technique that is used for clinical diagnostic imaging, as well as research applications in healthcare, the pharmaceutical industry, and even plant physiology. In this presentation, Dr. Lee discussed her work to develop rapid methods for preparing [11C]auxin and [11C]indole via [11C]cyanation for PET imaging. Automation of the synthesis of both radiotracers was conducted so they could be used for plant PET imaging with the goal of understanding plant physiology and phenotyping. The talk also covered the work in her lab developing fundamental methodology for nucleophilic C-H radiofluorination reactions with Ag18F and K18F via metal catalyzed C-H activation reactions that enable the late-stage formation of C-18F bonds to prepare PET radiotracers and radioligands. Finally, their work to design an efficient automated route to produce [18F]ASEM, a PET radioligand for imaging of α7-nAChR in the human brain, to support their clinical research was covered.

Gordon Lecture: Deep Learning MR Reconstruction from Missing Data

08/12/2019


Jong Chul Ye is currently KAIST Endowed Chair Professor and Professor of the Dept. of Bio/Brain Engineering and Adjunct Professor at Dept. of Mathematical Sciences of Korea Advanced Institute of Science and Technology (KAIST), Korea. He received the B.Sc. and M.Sc. degrees from Seoul National University, Korea, and the Ph.D. from Purdue University, West Lafayette.
Below is a summary of his presentation

Recently, deep learning approaches with various network architectures have achieved significant performance improvement over existing iterative reconstruction methods in accelerated MRI problems.  However, it is still unclear why these deep learning architectures work for specific problems. Moreover, in contrast to the usual evolution of signal processing theory around the classical theories, the link between deep learning and the classical image processing approaches are not yet well understood. In this talk, Dr. Ye reviewed the recent advances of deep learning approaches for accelerated MRI and their link between compressed sensing approaches. 

In particular, Dr. Ye first reviewed the variational neural network that was first proposed in MR field,  and the popular feed-forward neural network approaches using U-Net, which can remove undersampling artifacts from the aliasing artifact corrupted image. Then, he reviewed several advanced approaches such as AUTOMAP, CascadeNet, KiKi-Net, MoDL, etc. Finally, he demonstrated that the neural network approaches can be directly implemented in k-space domain to interpolate the missing k-space data.   In order to explore the theoretical origin of the success of the neural network for accelerated MRI, Dr. Ye reviewed some of the mathematical principles that have been proposed to explain the neural networks for inverse problems, which includes unfolding, convolution framelets, etc.  Then, he introduced recent mathematical discovery of the expressivity, generalization power and optimization landscape that give us hint to understand the power of AI for accelerated MRI.

Gordon Lecture: Machine Learning for Real-time High-quality Biomedical Imaging

07/19/2019


Leslie Ying is currently a Professor of Biomedical Engineering and Electrical Engineering at the University at Buffalo, SUNY. She received her B.E. in Electronics Engineering from Tsinghua University, China in 1997 and both her M.S. and Ph.D. in Electrical Engineering from the University of Illinois at Urbana - Champaign in 1999 and 2003, respectively.
Below is a summary of her presentation

Machine learning has recently attracted a lot of attention in biomedical imaging. It has shown success in biomedical image classifications but only very recently been used for image reconstruction with unique features. For this talk, Dr. Ying started with compressed sensing (CS), a strategy for reconstruction from sub-Nyquist sampled data. Several machine-learning-based methods were introduced within the conventional CS framework. She then explained how the optimization algorithm underlying CS can be unrolled to a deep artificial neural network, such that parameters and prior models can be learned from training samples. Finally, end-to-end convolutional neural networks were presented based on the training data with little knowledge of the imaging system. Connections among different networks were discussed with their benefits and limitations highlighted. Although most examples provided were from MRI, the frameworks are generalizable to image reconstruction problems for most imaging modalities. The talk concluded with future outlooks.

Gordon Lecture: Learn Deeply to Advance Medical Imaging: Artificial Intelligence in MR and PET/MR


Dr. Fang Liu is an assistant scientist at the University of Wisconsin School of Medicine and Public Health.  Dr. Liu obtained his Ph.D. in 2015 from Medical Physics at the University of Wisconsin and completed two years of postdoctoral training at the Radiology department. Dr. Liu has extensive research experience in the technical development of MR imaging for MR pulse sequence design, image reconstruction, quantitative imaging, and image analysis.
Below is a summary of his presentation

Medical imaging is a research field that remains plenty of technical and clinical challenges. The recent development of Artificial Intelligence, particularly Deep Learning (DL), has demonstrated high potentials to resolve such challenges. Dr. Liu presented some of his recent work for DL theory development and applications in medical imaging and will discuss the performance, strengths, and limitations. The talk gave an overview of DL in medical imaging and discuss some recent DL applications that successfully translate new learning-based approaches into performance improvement in MR and PET/MR imaging workflow.  One primary aim is to draw tightly connections between fundamental DL concepts and clinically relevant challenges in medical imaging. Topics covered rapid MR image acquisition, reconstruction and MR quantitative mapping, and image post-processing such as image segmentation and synthesis in MR and PET/MR, and finally lead to DL augmented disease diagnosis and prediction. The talk concluded with a discussion of open problems in DL that are particularly relevant to medical imaging and the potential challenges and opportunities in this emerging field.

Gordon Lecture: Broadband Photon Tomography

06/28/2019


Prof. Frederik J. Beekman Ph.D. heads the section Radiation, Detection & Medical Imaging at TU Delft University. He co-authored over 150 journal papers and is the inventor on 31 patents. His research interests includes biomedical imaging science, AI and image guided radio(-nuclide) therapy.  He is an associate editor of several journals and founder and CEO/CSO of MILabs (www.milabs.com) that develops and markets high performance biomedical imaging systems.
Below is a summary of his presentation

High Performance Integrated 4x4D PET, SPECT, Optical & X-ray Tomography

In preclinical research scientists have dreamed about a 3D magnifying glass that would allow us to e.g. see various cell functions and structures in a dynamic 4D single scan, and map integrated detailed dynamics of e.g. contrast agents, tracers, pharmaceuticals, receptors and indicators of therapy response in tumours. To meet these and many other imaging needs Dr. Beekman and his lab developed the user friendly fully integrated VECTor-6 imaging platform (WMIC innovation of the Year 2018) comprising:In preclinical research scientists have dreamed about a 3D magnifying glass that would allow us to e.g. see various cell functions and structures in a dynamic 4D single scan, and map integrated detailed dynamics of e.g. contrast agents, tracers, pharmaceuticals, receptors and indicators of therapy response in tumours. To meet these and many other imaging needs Dr. Beekman and his lab developed the user friendly fully integrated VECTor-6 imaging platform (WMIC innovation of the Year 2018) comprising:

A) down to ~0.1 mm SPECT & 0.55 mm PET resolution, with positron-range free PET for otherwise “difficult isotopes” like 124I, 76Br, 86Y, and 82Rb.  B) concurrent sub-mm multi-tracer PET & PET-SPECT  C) sub-second dynamic PET & SPECT  D) sub-mm resolution imaging of α & β-emitting pharmaceuticals,  E)  ultra-high performance low dose X-ray CT and  F) optical tomography (Cherenkov, Fluorescence & Bioluminescence)

In this presentation this highly adaptive and versatile nuclear, optical and structural imaging platform was explained along with many scientific applications contributed by hundreds of worldwide users. Finally, the results of translating their nuclear imaging technologies into <3 mm resolution clinical SPECT (G-SPECT, WMIS Innovation of the Year 2015) was presented.

Gordon Lecture: Radiopharmaceutical Therapy: History, Current Status and Future Potential

06/04/2019


Bennett S. Greenspan, M.D., M.S. received his M.D. degree from the University of Illinois in Chicago. He completed residencies in Diagnostic Radiology and Nuclear Medicine and is certified in Diagnostic Radiology and Nuclear Radiology by the ABR and in Nuclear Medicine by the ABNM. He received the M.S. degree in medical physics from UCLA. Dr. Greenspan is devoted to teaching of clinical nuclear medicine and also physics and radiation safety of nuclear medicine to nuclear medicine and radiology residents.  He is also keenly interested in quality and safety in Nuclear Medicine.
Below is a summary of his presentation

History - Radiopharmaceutical therapy began in 1941 with the efforts and insight of Saul Hertz, MD of MGH and also Arthur Roberts, PhD of MIT. From that beginning, I-131 has become an important agent for the treatment of benign and malignant thyroid disease. In the 1980s, two agents, Sr-89 chloride and Sm-153 EDTMP, were introduced for bone pain palliation. Somatostatin receptor targeted therapies were developed in the 1980s and 1990s, leading to FDA-approval of Lu-177 Dotatate in 2018. Radiolabeled antibodies were also being developed in the 1970s – 2000s, with the introduction of two agents in 2002 and 2003. Radium-223 dichloride was approved by the FDA in 2013 for treatment of castrate-resistant metastatic prostate cancer.

Read more...

Gordon Lecture: Preoperative and Intraoperative Localization for Pulmonary nodule


Dr. Hyun Koo Kim is Professor and Chief of Thoracic and Cardiovascular Surgery at the Korea University Guro Hospital in Seoul, Korea. He earned his medical degree from Korea University College of Medicine in Seoul Korea in 1996. He finished a Thoracic and Cardiovascular Surgery residency in 2001 and afterwards completed a fellowship in the Korea University Guro Hospital in 2005. He is an expertise in single port VATS and utilizing 3D thoracoscope during VATS.
Below is a summary of his presentation

Image-guided surgery can be defined as surgery where the operator utilizes surgical devices that incorporate the use of tracking technology in conjunction with a fusion of images in order to guide surgical procedures. 

Preoperative marking via CT-guided localization is the most commonly used techniques for thoracoscopic surgery-based resection of small peripheral pulmonary nodules. But, it was related with resulting in higher rates of pneumothorax, bleeding, and dislodgement.Preoperative marking via CT-guided localization is the most commonly used techniques for thoracoscopic surgery-based resection of small peripheral pulmonary nodules. But, it was related with resulting in higher rates of pneumothorax, bleeding, and dislodgement.

Read more...

Gordon Lecture: Advanced MRIs in CNS

05/20/2019


Dr. Meiyun Wang is a neuroradiologist, Professor and Chair of the Medical Imaging Center of Henan Province and Chair of the Department of Radiology of Henan Provincial People’s Hospital. She received her M.D. from Southeast University in 1995, a PhD from Capital University of Medical Sciences in 2005, and then worked as a post-doctoral research fellow at the Massachusetts General Hospital, Harvard Medical School from 2006-2008. She became the Vice-Chair in 2008 Chair in 2016 of the Department of Radiology of Henan Provincial People’s Hospital in China.
Below is a summary of her presentation.

In this talk, the applications of three non-contrast enhanced advanced MR techniques, including Diffusion Kurtosis Imaging (DKI), Strategically Acquired Gradient Echo (STAGE) and a Length and Offset Varied Saturation (LOVARS) in central nervous system (CNS) were summarized.

DKI has been used to measure non-Gaussian diffusion, which has the potential to characterize both normal and pathologic tissue better than diffusion-tensor imaging. Some previous researchers have suggested that DKI might provide more accurate information about water diffusion. Dr. Wang's study showed that mean kurtosis values may provide additional information and improve the grading of gliomas compared with conventional diffusion parameters.

STAGE is an advanced Susceptibility weighted imaging (SWI) which can provide multi-contrast images in one scan, such as T1W, PDW, T1 MAP, PD MAP, R2* MAP, SWI, and even MRA images in 5 minutes. It is very helpful in early detecting and evaluating ischemia, brain trauma and some other CNS diseases.

Read more...